Ultra Nasdaq Biotechnology (BIB) is a ProShares ETF with a 0.95% expense ratio, 256 holdings and $93MM in net assets. Largest sector: Healthcare (100%).
Fee
0.95%
expense ratio
Net assets
$93MM
Launched
Apr 7, 2010
Holdings
256
as of Oct 27, 2026
Top 10 weight
156.0%
over 100%: swaps and futures
Largest sector
Healthcare
100.0%
Yield
—
Benchmark
—
BIB's holdings are as of Oct 27, 2026.
Healthcare
100.0%
Sectors are known for only 32% of BIB; the rest is holdings without one (swaps, futures, bonds, cash or unclassified stocks), so this split describes that part of the fund.
1
—
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA
33.73%
2
—
NASDAQ BIO INDEX SWAP BNP PARIBAS
32.60%
3
—
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA
29.91%
4
—
NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL
19.04%
5
—
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE
18.13%
6
GILD
GILEAD SCIENCES
5.35%
7
AMGN
AMGEN
5.13%
8
VRTX
VERTEX PHARMACEUTICALS
4.71%
9
—
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG
4.54%
10
MRNA
MODERNA
3.35%
11
REGN
REGENERON PHARMACEUTICALS
3.33%
12
ILMN
ILLUMINA
1.70%
13
RVMD
Revolution Medicines
1.61%
14
BIIB
BIOGEN
1.50%
15
ALNY
Alnylam Pharmaceuticals
1.22%
16
RPRX
ROYALTY PHARMA
1.17%
17
ROIV
Roivant Sciences Ltd.
1.06%
18
UTHR
United Therapeutics
1.02%
19
ARGX
ARGENX
0.97%
20
GH
Guardant Health
0.96%
21
INCY
INCYTE
0.95%
22
VTRS
VIATRIS
0.87%
23
INSM
Insmed
0.83%
24
MEDP
Medpace Holdings
0.76%
25
EXEL
Exelixis
0.65%
1–25 of 256